Observations on patents and other IP from a dual-licensed practitioner
Once upon a time the New York Times was a respected publication. These days it’s overpriced toilet paper (and not very soft at that, let alone perforated for easy use).…
James Meigs has a piece in the newest edition of Commentary entitled "Thank God For Big Pharma". It doesn't say anything that's not already familiar to people involved in the…
Yesterday I wrote about Tom Lehrer dedicating his songs to the public. Turns out that his output includes a song that’s a wonderful illustration of technological obsolescence. But a word…
The hottest story in Israeli biotech in 2017 was the August acquisition of Kite Pharma by Gilead Sciences for 11.9 billion dollars, and the announcement in October of FDA approval…
I’m Dan Feigelson. I’ve been practicing patent law for over 30 years. I’m also opinionated, as you may discover in reading my writings here.